经肛门改良Soave术与经腹手术治疗先天性巨结肠的临床疗效及安全性比较  被引量:4

Comparison of clinical efficacy and safety of transanal modified Soave and transabdominal surgery treating Hirschsprung disease

在线阅读下载全文

作  者:郭秋鹏 户佐珍 何浔 吴岳[1] 李俊杰 王勇[1] 

机构地区:[1]江西省九江市妇幼保健院江西省九江市儿童医院儿外科,江西九江332000

出  处:《中国当代医药》2017年第31期112-114,共3页China Modern Medicine

摘  要:目的比较经肛门改良Soave术和经腹手术治疗先天性巨结肠的临床效果和安全性。方法选取我院2014年1月~2017年6月收治的先天性巨结肠患儿100例,将其随机分为对照组(50例)和观察组(50例),分别给予经腹手术和经肛门改良Soave术治疗。比较两组患者的手术时间、胃肠功能恢复时间、住院时间,排便功能以及并发症发生情况。结果观察组的手术时间、胃肠功能恢复时间、住院时间显著短于对照组(P<0.05)。观察组完全自主大便比例显著高于对照组,污粪比例低于对照组,差异有统计学意义(P<0.05)。观察组的并发症发生率为6.00%,显著低于对照组的28.00%(P<0.05)。结论先天性巨大结肠采用经肛门改良Soave术治疗的效果更显著,安全性高,可以作为先天性巨大结肠的首选术式。Objective To compare the clinical effect and safety of transanal modified Soave and transabdominal surgery treating Hirschsprung disease.Methods 100 children with Hirschsprung disease treated in our hospital from January 2014 to June 2017 were selected and they were randomly divided into the control group (50 cases) and the observation group (50 cases),and abdominal surgery and transanal modified Soave was performed respectively.The operation time,gastroin- testinal function recovery time,hospitalization time,detecation function and incidence of complications were compared between the two groups.Results The operation time,the recovery time of gastrointestinal function and hospitalization time in the observation group were significantly shorter than those in the control group (P〈0.05).The proportion of fully autonomous stool in the observation group was significantly higher than that in the control group,and the proportion of fecal manure was lower than that of the control group,the difference was statistically significant (P〈0.05).The incidence of complications of the observation group was 6.0%,which was significantly lower than that of the control group (28.0%) (P〈0.05).Conclusion Transanal modified Soave is more effective and safe in the treatment of congenital giant colon.It can be used as the first choice for congenital giant colon.

关 键 词:经肛门改良Soave术 经腹手术 先天性巨结肠 疗效 安全性 

分 类 号:R726.1[医药卫生—儿科]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象